Qanti Gastric HER2

Home

Product

Qanti® Gastric HER2

UPCOMING

Description

Qanti® Gastric HER2 is designed to assist anatomic pathologists in the quantitative cell counts and semi-quantitative HER2 IHC score interpretation in gastric and gastroesophageal junction cancer.

Scoring System

Following ASCO/CAP 2017 Gastroesophageal HER2 Interpretation Guidelines
HER2 0, 1+, 2+, and 3+

comparison-after

comparison-before

Recent Publications

Artificial Intelligence-Assessed Tumor Central Tumor-Infiltrating Lymphocytes Predict Recurrence-Free Survival in Transurethral Resection of Bladder Tumor Specimens

Artificial Intelligence-Assessed Tumor Central Tumor-Infiltrating Lymphocytes Predict Recurrence-Free Survival in Transurethral Resection of Bladder Tumor Specimens

A Nationwide Study of Interobserver Agreement and Accuracy in HER2 Immunohistochemistry According to the 2025 CAP HER2 Scoring Guideline and the Impact of Augmented Intelligence on HER2 Interpretation

A Nationwide Study of Interobserver Agreement and Accuracy in HER2 Immunohistochemistry According to the 2025 CAP HER2 Scoring Guideline and the Impact of Augmented Intelligence on HER2 Interpretation

Enhancing Ki-67 Quantification by Tumor Cell Detection Using a Vision Transformer-Based Model

Enhancing Ki-67 Quantification by Tumor Cell Detection Using a Vision Transformer-Based Model

Latest News

AimedBio Announces Strategic Investment and Joint Research with AIVIS in AI-Based Biomarker Quantification

AimedBio Announces Strategic Investment and Joint Research with AIVIS in AI-Based Biomarker Quantification

February 3, 2026

AIVIS Wins Minister of Science and ICT Award at Cloud Performance Sharing Conference

AIVIS Wins Minister of Science and ICT Award at Cloud Performance Sharing Conference

December 31, 2025

AIVIS Wins 2025 DATA-Global Minister's Award from the Ministry of Science and ICT

AIVIS Wins 2025 DATA-Global Minister's Award from the Ministry of Science and ICT

December 30, 2025

For more information